Talk:Posterior reversible encephalopathy syndrome

Latest comment: 1 year ago by Jfdwolff in topic Additional source

MRIs

edit

Most of the article consisted of an MRI dataset. I'm not sure if there is any point in showing all the images. I'm moving it here for the time being. JFW | T@lk 20:39, 13 April 2009 (UTC)Reply

Expanding

edit

I've picked some recent sources that would be useful for further expansion. The Garg paper and the Pula paper are fairly good, but for the neuroradiological discussions I think we should also cite these (both by Bartynski): PMID 18356474 and PMID 18403560, and think about touching on PMID 18268188 (recent large case series). JFW | T@lk 20:52, 13 April 2009 (UTC)Reply

Medications

edit

Rytyho usa (talk · contribs) added the following list of medicines associated with PRES, but omitted a source. Apart from the fact that we should be avoiding bullet-point lists, there was no source and some are implausible (like dexamethasone).

A source would resolve this issue. JFW | T@lk 09:01, 24 May 2013 (UTC)Reply

Jfdwolff (talk · contribs), here is the source I used for that information:
Rajasekhar, A. (2007 Nov). "Gemcitabine-Induced Reversible Posterior Leukoencephalopathy Syndrome: A Case Report and Review of the Literature". The Oncologist. 12 (11): 1332–1335. doi:10.1634/theoncologist.12-11-1332. PMID 18055853. {{cite journal}}: Check date values in: |date= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
Not a great source, I'm affraid. This table is from a secondary source. Should we use that instead? JFW | T@lk 20:17, 24 June 2013 (UTC)Reply

Lancet Neurol review

edit

doi:10.1016/S1474-4422(15)00111-8 JFW | T@lk 18:25, 12 January 2016 (UTC)Reply

Histopathology: doi:10.1093/jnen/nlx112 JFW | T@lk 15:39, 6 May 2020 (UTC)Reply
doi:10.1016/j.jns.2019.07.018 focuses on imaging. JFW | T@lk 15:39, 6 May 2020 (UTC)Reply
doi:10.1097/WCO.0000000000000640 - general review. JFW | T@lk 15:39, 6 May 2020 (UTC)Reply

Additional source

edit

doi:10.1136/practneurol-2021-003194 JFW | T@lk 09:05, 29 May 2023 (UTC)Reply